Evidence map›Paper›PMID 39207021›Full record

ArticleThe Journal of infectious diseases2025

A Decade of Chronic Norovirus Infection Surveillance at the National Institutes of Health Clinical Research Center: Clinical Characteristics, Molecular Epidemiology, and Replication.

Natthawan Chaimongkol, Daniel Y Kim, Yuki Matsushima, Jessica Durkee-Shock, Karenna Barton, Courtney N Ahorrio, Gary A Fahle, Karin Bok, Allison Behrle-Yardley, Jordan A Johnson and 6 more

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Current infectious disease management challenges in inborn errors of immunity.Annals of clinical microbiology and antimicrobials · 2025
    Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Natthawan ChaimongkolCaliciviruses Section.
Daniel Y KimCaliciviruses Section.
Yuki MatsushimaCaliciviruses Section.
Jessica Durkee-ShockMedical Virology Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.ORCID 0000-0003-0984-6881
Karenna BartonMedical Virology Section, Laboratory of Infectious Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.
Courtney N AhorrioCaliciviruses Section.
Gary A FahleDepartment of Laboratory Medicine, Clinical Research Center, National Institutes of Health, Bethesda, Maryland.
Karin BokCaliciviruses Section.
Allison Behrle-YardleyCaliciviruses Section.
Jordan A JohnsonCaliciviruses Section.
Dennise A de Jesús-DíazCaliciviruses Section.
Gabriel I ParraCaliciviruses Section.
Eric A LevensonCaliciviruses Section.
Fernando Yukio MaedaCaliciviruses Section.
Stanislav V SosnovtsevCaliciviruses Section.
Kim Y GreenCaliciviruses Section.ORCID 0000-0002-8189-7352

Funding

NHLBI NIH HHSNIAIDNIH
6 · The paper itself

Abstract

backgroundNoroviruses are an important viral cause of chronic diarrhea in immunocompromised individuals.

methodsWe collected norovirus-positive stool samples (n = 448) from immunocompromised patients (n = 88) at the National Institutes of Health (NIH) Clinical Research Center from 2010 to 2022. We assessed norovirus molecular epidemiology and infectivity in human intestinal enteroid (HIE) monolayers and clinical characteristics of the cohort.

resultsNoroviruses were genetically diverse: both genogroup I (GI.2, GI.5 and GI.6) and genogroup II (GII.1-GII.4, GII.6, GII.7, GII.12, GII.14, and GII.17) genotypes were detected, with GII.4 variants (Osaka, Apeldoorn, Den Haag, New Orleans, and Sydney) predominant (51/88 [57.9%]). Viruses belonging to the GII.4 Sydney variant group that replicated in HIEs (n = 9) showed a higher fold-increase in RNA genome copies compared to others that replicated. Chronic norovirus infection was documented in thirty-nine patients with shedding levels ranging from 104 to 1011 genome copies/g of stool. The majority (32/39 [82%]) had clinical evidence of an inborn error of immunity (13 identified monogenic diseases), most with combined immunodeficiency (15 of 32) or common variable immunodeficiency (11 of 32).

conclusionsGenetically and biologically diverse noroviruses established chronic infection in NIH patients with both inborn and acquired immunologic defects.

Indexed as

Caliciviridae InfectionsGastroenteritisNorovirusAdolescentAdultAgedChronic DiseaseFecesFemaleGenotypeHumansImmunocompromised HostMaleMiddle AgedMolecular EpidemiologyNational Institutes of Health (U.S.)chronic norovirusimmunocompromisedinborn errors of immunityintestinal enteroidsmolecular epidemiology

Identifiers

PMID39207021
PMCPMC11911794

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.